Celgene’s Otezla receive FDA approval for treating psoriatic arthritis
PRESS RELEASE The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA). PsA is a form of arthritis that affects some people with psoriasis. Most More...